Citi Upgrades Biogen (BIIB) to Buy

February 8, 2013 6:53 AM EST Send to a Friend
Get Alerts BIIB Hot Sheet
Price: $303.55 +1.49%

Rating Summary:
    21 Buy, 8 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 13 | Down: 18 | New: 41
Trade BIIB Now!
Join SI Premium – FREE
Citi upgraded Biogen (NASDAQ: BIIB) from Neutral to Buy with a price target of $187.00 (from $160.00).

For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.

Shares of Biogen closed at $160.30 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change, Upgrades

Related Entities

Citi

Add Your Comment